Menu Menu

RXRX    Recursion Pharmaceuticals Inc    1601830    
Income Statement
Revenue rxrx-20240930 26,082,000
Net Income rxrx-20240930 -95,842,000
Profit Margin -367.46%

Balance Sheet
Current Assets 474,172,000
Assets 726,499,000
Current Liabilities 108,888,000
Liabilities 201,940,000
Equity 524,559,000
Shares Out 275,070,000

Cash Flow Statement
Operating Cash Flow -243,744,000
Investing Cash Flow -15,397,000

Market Analysis
Market Cap 1,928,815,890
Price 6.53
BVPS 1.91
PB 3.41
EPS -1.63
PS 18.49
FCF -259,141,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/27 -0.42
Apr May Jun
5/09 -0.39
Jul Aug Sep
8/08 -0.40
Oct Nov Dec
11/07

Find a discrepancy? The most accurate way to find company fundamental data is to view RXRX documents filed with the SEC.


RXRX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas